余龙 Long Yu

       


   教授,国家杰出青年基金获得者

       ProfessorCheung Kong ScholarOutstanding Young Scientist of China

         Emaillongyu@fudan.edu.cn

 

Ø  主要经历

1970.11-1974.8 中国人民解放军基建工程兵部队,战士、班长

1974.9-1978.2  第一军医大学,本科

1978.3-1982.7  中国人民解放军基建工程兵部队,军医、所长

1982.8-1986.2  中山医科大学,硕士

1986.2-1987.2  中山医科大学第一临床医学院,医师

1987.2-1990.10 中山医科大学,博士

1990.11-1992.10,复旦大学,博士后

1992.11-1993.2 复旦大学,讲师

1993.3-1995.4  复旦大学,副教授

1995-今,       复旦大学,教授

1999-2002     复旦大学遗传工程国家重点实验室,常务副主任

2002-2012     复旦大学遗传工程国家重点实验室,主任

 

Ø  Main Experiences

1974-1978B.A.First Military Medical University

1985-1990M.D.Sun Yat-Sen Medical University

1990-1993Post-doctoral fellowFudan University

1993-1995Associate professorFudan University

1995-presentProfessorFudan University

1998-2002Deputy DirectorState Key Laboratory of Genetic Engineering

2002-presentDirectorState Key Laboratory of Genetic Engineering

 

Ø  主要科研领域

肝癌发生的分子遗传学机制研究和抗肝癌药物小分子化合物筛选、以及重大疾病相关基因的系统生物学及药物开发研究。

 

Ø  Main Research Fields

Our interest mainly focuses on the molecular genetic mechanisms of HCC progression, screening of small molecules for anti-HCC drugs, as well as systematic biology study and drug development of major disease-related genes.

 

Ø  Selected Publications

1.     Jiang, D. K., Sun, J., Cao, G., Liu, Y., Lin, D., Gao, Y. Z., ... & Liu, J. (2013). Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nature genetics, 45(1), 72-75.

2.     Xiao, Q., Qu, K., Wang, C., Kong, Y., Liu, C., Jiang, D., ... & Yu, L. (2013). HDGF-related protein-3 is required for anchorage-independent survival and chemoresistance in hepatocellular carcinomas. Gut, 62(3), 440-451.

3.     Liu, G., Jiang, S., Wang, C., Jiang, W., Liu, Z., Liu, C., ... & Yu, L. (2012). Zinc finger transcription factor 191, directly binding to β‐catenin promoter, promotes cell proliferation of hepatocellular carcinoma. Hepatology, 55(6), 1830-1839.

4.     Huang, W., Ding, L., Huang, Q., Hu, H., Liu, S., Yang, X., ... & Yu, L. (2010). Carbonyl reductase 1 as a novel target of (−)epigallocatechin gallate against hepatocellular carcinoma. Hepatology, 52(2), 703-714.

5.     Wu, Y., Zuo, J., Ji, G., Saiyin, H., Liu, X., Yin, F., ... & Yu, L. (2009). Proapoptotic function of integrin β3 in human hepatocellular carcinoma cells. Clinical Cancer Research, 15(1), 60-69.